Evaluation of Orlistat as Adjuvant Treatment of Obesity in Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

638

Participants

Timeline

Start Date

September 30, 2016

Primary Completion Date

December 31, 2017

Study Completion Date

December 21, 2017

Conditions
Obesity
Interventions
DRUG

Orlistat 60 mg

1 tablet 3 times a day

OTHER

Placebo

1 tablet 3 times a day

Trial Locations (5)

13010001

Loema, Campinas

Unknown

Centro de Medicina Reprodutiva Dr Carlos Isaia Filho, Porto Alegre

Allergisa, Campinas

CIPMED, Jaú

Marcio Antonio Pereira Clinica de Endocrinologia, São José dos Campos

Sponsors

Lead Sponsor

All Listed Sponsors
lead

EMS

INDUSTRY